Fitch Ratings has assigned a Neutral rating to the global pharmaceutical and biotech industry, which indicates the assumption of a collaborative operating backdrop in 2023, although inflationary pressures.
United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company engaged in the development and commercialization of medical products and therapies to address the unmet needs of patients with .
United Therapeutics Corporation (NASDAQ:NASDAQ:UTHR) Q3 2022 Earnings Conference Call November 02, 2022 9:00 AM ET Company Participants Dewey Sedman – Head-Investor Relations Martine.